Equest
Active substance
ATC code
Species
Horses and ponies.
Indications
The veterinary medicinal product is indicated for treatment of infections caused by moxidectin sensitive strains of:
- Large strongyles:
. Strongylus vulgaris (adults and arterial stages)
. Strongylus edentatus (adults and visceral stages)
. Triodontophorus brevicauda (adults)
. Triodontophorus serratus (adults)
. Triodontophorus tenuicollis (adults)
- Small strongyles (adults and intraluminal larval stages):
. Cyathostomum spp.
. Cylicocyclus spp.
. Cylicostephanus spp.
. Cylicodontophorus spp.
. Gyalocephalus spp.
- Ascarids:
. Parascaris equorum (adult and larval stages)
- Other species:
. Oxyuris equi (adult and larval stages)
. Habronema muscae (adults)
. Gasterophilus intestinalis (L2, L3)
. Gasterophilus nasalis (L2, L3)
. Strongyloides westeri (adults)
. Trichostrongylus axei
The veterinary medicinal product has a persistent efficacy of two weeks against small strongyles. The excretion of small strongyles eggs is suppressed for 90 days.
The veterinary medicinal product is effective against (developing) intramucosal L4 stages of small strongyles. At 8 weeks after treatment, early (hypobiotic) EL3 stages of small strongyles are eliminated.
Dose to be administered and administration route
Oral use.
Single administration of 400 µg moxidectin/kg bodyweight using the calibrated syringe.
Each syringe treats a 700 kg horse.
Bodyweight and dosage should be accurately determined prior to treatment.
Underdosing could result in ineffective use and may favour resistance development. Use of a scale or weight tape is recommended to ensure accurate dosing.
Dosing instructions
Before the first dose, hold the syringe with the capped end pointing to the left and so that you can see the weight measurements and tick marks (small black lines). Set the syringe to zero by moving the dial ring so the left side is set at the first full black mark and depress the plunger, safely discarding any paste that is expelled.
To dose the product, hold the syringe as previously described. Each tick mark relates to 25 kg of bodyweight and to 10 mg moxidectin. Turn the dial ring until the left side of the ring lines up with the weight of the animal.
Adverse reactions
Horses and ponies:
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Abdominal pain1 Swollen muzzle1 Ataxia1, muscle tremor1, droopy lower lip1 Depression1 |
1 In young animals. These adverse effects are usually transient and disappear spontaneously in most cases.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
